img

Global Alzheimer Drug Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Alzheimer Drug Market Research Report 2024

According to MRA Research’s new survey, global Alzheimer Drug market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alzheimer Drug market research.
Key companies engaged in the Alzheimer Drug industry include Biogen, Eli Lilly and Alzheon, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of Alzheimer Drug were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole Alzheimer Drug market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Alzheimer Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biogen
Eli Lilly
Alzheon
Segment by Type
Aducanumab
Donepezil
Rivastigmine
Memantine
Others

Segment by Application


Mild Alzheimer
Moderate Alzheimer
Severe Alzheimer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Alzheimer Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer Drug Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Aducanumab
1.2.3 Donepezil
1.2.4 Rivastigmine
1.2.5 Memantine
1.2.6 Others
1.3 Market by Application
1.3.1 Global Alzheimer Drug Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Mild Alzheimer
1.3.3 Moderate Alzheimer
1.3.4 Severe Alzheimer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer Drug Market Perspective (2018-2033)
2.2 Alzheimer Drug Growth Trends by Region
2.2.1 Global Alzheimer Drug Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Alzheimer Drug Historic Market Size by Region (2018-2023)
2.2.3 Alzheimer Drug Forecasted Market Size by Region (2024-2033)
2.3 Alzheimer Drug Market Dynamics
2.3.1 Alzheimer Drug Industry Trends
2.3.2 Alzheimer Drug Market Drivers
2.3.3 Alzheimer Drug Market Challenges
2.3.4 Alzheimer Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer Drug Players by Revenue
3.1.1 Global Top Alzheimer Drug Players by Revenue (2018-2023)
3.1.2 Global Alzheimer Drug Revenue Market Share by Players (2018-2023)
3.2 Global Alzheimer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer Drug Revenue
3.4 Global Alzheimer Drug Market Concentration Ratio
3.4.1 Global Alzheimer Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Drug Revenue in 2023
3.5 Alzheimer Drug Key Players Head office and Area Served
3.6 Key Players Alzheimer Drug Product Solution and Service
3.7 Date of Enter into Alzheimer Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer Drug Breakdown Data by Type
4.1 Global Alzheimer Drug Historic Market Size by Type (2018-2023)
4.2 Global Alzheimer Drug Forecasted Market Size by Type (2024-2033)
5 Alzheimer Drug Breakdown Data by Application
5.1 Global Alzheimer Drug Historic Market Size by Application (2018-2023)
5.2 Global Alzheimer Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Alzheimer Drug Market Size (2018-2033)
6.2 North America Alzheimer Drug Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Alzheimer Drug Market Size by Country (2018-2023)
6.4 North America Alzheimer Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer Drug Market Size (2018-2033)
7.2 Europe Alzheimer Drug Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Alzheimer Drug Market Size by Country (2018-2023)
7.4 Europe Alzheimer Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer Drug Market Size (2018-2033)
8.2 Asia-Pacific Alzheimer Drug Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Alzheimer Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Alzheimer Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer Drug Market Size (2018-2033)
9.2 Latin America Alzheimer Drug Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Alzheimer Drug Market Size by Country (2018-2023)
9.4 Latin America Alzheimer Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer Drug Market Size (2018-2033)
10.2 Middle East & Africa Alzheimer Drug Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Alzheimer Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Alzheimer Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Alzheimer Drug Introduction
11.1.4 Biogen Revenue in Alzheimer Drug Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Alzheimer Drug Introduction
11.2.4 Eli Lilly Revenue in Alzheimer Drug Business (2018-2023)
11.2.5 Eli Lilly Recent Development
11.3 Alzheon
11.3.1 Alzheon Company Detail
11.3.2 Alzheon Business Overview
11.3.3 Alzheon Alzheimer Drug Introduction
11.3.4 Alzheon Revenue in Alzheimer Drug Business (2018-2023)
11.3.5 Alzheon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Alzheimer Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Aducanumab
Table 3. Key Players of Donepezil
Table 4. Key Players of Rivastigmine
Table 5. Key Players of Memantine
Table 6. Key Players of Others
Table 7. Global Alzheimer Drug Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 8. Global Alzheimer Drug Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 9. Global Alzheimer Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Alzheimer Drug Market Share by Region (2018-2023)
Table 11. Global Alzheimer Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Alzheimer Drug Market Share by Region (2024-2033)
Table 13. Alzheimer Drug Market Trends
Table 14. Alzheimer Drug Market Drivers
Table 15. Alzheimer Drug Market Challenges
Table 16. Alzheimer Drug Market Restraints
Table 17. Global Alzheimer Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Alzheimer Drug Market Share by Players (2018-2023)
Table 19. Global Top Alzheimer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2023)
Table 20. Ranking of Global Top Alzheimer Drug Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Alzheimer Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alzheimer Drug Product Solution and Service
Table 24. Date of Enter into Alzheimer Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Alzheimer Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Alzheimer Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Alzheimer Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Alzheimer Drug Revenue Market Share by Type (2024-2033)
Table 30. Global Alzheimer Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Alzheimer Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Alzheimer Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Alzheimer Drug Revenue Market Share by Application (2024-2033)
Table 34. North America Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 35. North America Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 38. Europe Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Alzheimer Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 41. Asia-Pacific Alzheimer Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Alzheimer Drug Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. Latin America Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Alzheimer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 47. Middle East & Africa Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 49. Biogen Company Detail
Table 50. Biogen Business Overview
Table 51. Biogen Alzheimer Drug Product
Table 52. Biogen Revenue in Alzheimer Drug Business (2018-2023) & (US$ Million)
Table 53. Biogen Recent Development
Table 54. Eli Lilly Company Detail
Table 55. Eli Lilly Business Overview
Table 56. Eli Lilly Alzheimer Drug Product
Table 57. Eli Lilly Revenue in Alzheimer Drug Business (2018-2023) & (US$ Million)
Table 58. Eli Lilly Recent Development
Table 59. Alzheon Company Detail
Table 60. Alzheon Business Overview
Table 61. Alzheon Alzheimer Drug Product
Table 62. Alzheon Revenue in Alzheimer Drug Business (2018-2023) & (US$ Million)
Table 63. Alzheon Recent Development
Table 64. Research Programs/Design for This Report
Table 65. Key Data Information from Secondary Sources
Table 66. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Alzheimer Drug Market Share by Type: 2023 VS 2033
Figure 3. Aducanumab Features
Figure 4. Donepezil Features
Figure 5. Rivastigmine Features
Figure 6. Memantine Features
Figure 7. Others Features
Figure 8. Global Alzheimer Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Alzheimer Drug Market Share by Application: 2023 VS 2033
Figure 10. Mild Alzheimer Case Studies
Figure 11. Moderate Alzheimer Case Studies
Figure 12. Severe Alzheimer Case Studies
Figure 13. Alzheimer Drug Report Years Considered
Figure 14. Global Alzheimer Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Alzheimer Drug Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 16. Global Alzheimer Drug Market Share by Region: 2023 VS 2033
Figure 17. Global Alzheimer Drug Market Share by Players in 2023
Figure 18. Global Top Alzheimer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Alzheimer Drug Revenue in 2023
Figure 20. North America Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Alzheimer Drug Market Share by Country (2018-2033)
Figure 22. United States Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Alzheimer Drug Market Share by Country (2018-2033)
Figure 26. Germany Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Alzheimer Drug Market Share by Region (2018-2033)
Figure 34. China Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Alzheimer Drug Market Share by Country (2018-2033)
Figure 42. Mexico Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Alzheimer Drug Market Share by Country (2018-2033)
Figure 46. Turkey Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Alzheimer Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Biogen Revenue Growth Rate in Alzheimer Drug Business (2018-2023)
Figure 49. Eli Lilly Revenue Growth Rate in Alzheimer Drug Business (2018-2023)
Figure 50. Alzheon Revenue Growth Rate in Alzheimer Drug Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed